Cargando…
The Evaluation of Hepatitis C Virus Core Antigen in Immunized Balb/C Mice
BACKGROUND: Hepatitis infection represents one of the important causes of morbidity and mortality in developing countries, however there is not any effective vaccine against hepatitis C which is one of the significant problems in vaccine project. OBJECTIVES: The aim of the present study is to evalua...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Kowsar
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3412556/ https://www.ncbi.nlm.nih.gov/pubmed/22879829 http://dx.doi.org/10.5812/hepatmon.6141 |
_version_ | 1782239961545703424 |
---|---|
author | Torbati, Elham Bandehpour, Mojgan Pakzad, Parviz Mosaffa, Nariman Koochaki, Ameneh Kazemi, Bahram |
author_facet | Torbati, Elham Bandehpour, Mojgan Pakzad, Parviz Mosaffa, Nariman Koochaki, Ameneh Kazemi, Bahram |
author_sort | Torbati, Elham |
collection | PubMed |
description | BACKGROUND: Hepatitis infection represents one of the important causes of morbidity and mortality in developing countries, however there is not any effective vaccine against hepatitis C which is one of the significant problems in vaccine project. OBJECTIVES: The aim of the present study is to evaluate the role of HCV core protein in inducing IFN-Gamma secretion and TCL activities as a vaccine in Balb/C mice. MATERIAL AND METHODS: Our previous cloned plasmid (HCV Core gene into pETDuet-1) applied for protein expression in bacteria. The expressed and purified recombinant protein together with Freund’s adjuvant was injected to 15 Balb/c mice. The total IgG and IgG2a of immunized mice sera were evaluated after a week. Two weeks after booster injection, we studied the proliferation and IFNγ secretion of spleens, inguinal and popliteal lymph nodes lymphocytes by ELISA and ELISPOT. RESULTS: The FSFC (Frequency of spot forming cells) of secreting cells of immunized mice with HCV/Core protein and sera IgG2a were considerably higher than the control groups. CONCLUSIONS: The core protein together with proper adjuvant can be a candidate vaccine against of HCV infection. |
format | Online Article Text |
id | pubmed-3412556 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Kowsar |
record_format | MEDLINE/PubMed |
spelling | pubmed-34125562012-08-09 The Evaluation of Hepatitis C Virus Core Antigen in Immunized Balb/C Mice Torbati, Elham Bandehpour, Mojgan Pakzad, Parviz Mosaffa, Nariman Koochaki, Ameneh Kazemi, Bahram Hepat Mon Original Article BACKGROUND: Hepatitis infection represents one of the important causes of morbidity and mortality in developing countries, however there is not any effective vaccine against hepatitis C which is one of the significant problems in vaccine project. OBJECTIVES: The aim of the present study is to evaluate the role of HCV core protein in inducing IFN-Gamma secretion and TCL activities as a vaccine in Balb/C mice. MATERIAL AND METHODS: Our previous cloned plasmid (HCV Core gene into pETDuet-1) applied for protein expression in bacteria. The expressed and purified recombinant protein together with Freund’s adjuvant was injected to 15 Balb/c mice. The total IgG and IgG2a of immunized mice sera were evaluated after a week. Two weeks after booster injection, we studied the proliferation and IFNγ secretion of spleens, inguinal and popliteal lymph nodes lymphocytes by ELISA and ELISPOT. RESULTS: The FSFC (Frequency of spot forming cells) of secreting cells of immunized mice with HCV/Core protein and sera IgG2a were considerably higher than the control groups. CONCLUSIONS: The core protein together with proper adjuvant can be a candidate vaccine against of HCV infection. Kowsar 2012-06 2012-06-30 /pmc/articles/PMC3412556/ /pubmed/22879829 http://dx.doi.org/10.5812/hepatmon.6141 Text en Copyright © 2012, Kowsar Corp. http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Torbati, Elham Bandehpour, Mojgan Pakzad, Parviz Mosaffa, Nariman Koochaki, Ameneh Kazemi, Bahram The Evaluation of Hepatitis C Virus Core Antigen in Immunized Balb/C Mice |
title | The Evaluation of Hepatitis C Virus Core Antigen in Immunized Balb/C Mice |
title_full | The Evaluation of Hepatitis C Virus Core Antigen in Immunized Balb/C Mice |
title_fullStr | The Evaluation of Hepatitis C Virus Core Antigen in Immunized Balb/C Mice |
title_full_unstemmed | The Evaluation of Hepatitis C Virus Core Antigen in Immunized Balb/C Mice |
title_short | The Evaluation of Hepatitis C Virus Core Antigen in Immunized Balb/C Mice |
title_sort | evaluation of hepatitis c virus core antigen in immunized balb/c mice |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3412556/ https://www.ncbi.nlm.nih.gov/pubmed/22879829 http://dx.doi.org/10.5812/hepatmon.6141 |
work_keys_str_mv | AT torbatielham theevaluationofhepatitiscviruscoreantigeninimmunizedbalbcmice AT bandehpourmojgan theevaluationofhepatitiscviruscoreantigeninimmunizedbalbcmice AT pakzadparviz theevaluationofhepatitiscviruscoreantigeninimmunizedbalbcmice AT mosaffanariman theevaluationofhepatitiscviruscoreantigeninimmunizedbalbcmice AT koochakiameneh theevaluationofhepatitiscviruscoreantigeninimmunizedbalbcmice AT kazemibahram theevaluationofhepatitiscviruscoreantigeninimmunizedbalbcmice AT torbatielham evaluationofhepatitiscviruscoreantigeninimmunizedbalbcmice AT bandehpourmojgan evaluationofhepatitiscviruscoreantigeninimmunizedbalbcmice AT pakzadparviz evaluationofhepatitiscviruscoreantigeninimmunizedbalbcmice AT mosaffanariman evaluationofhepatitiscviruscoreantigeninimmunizedbalbcmice AT koochakiameneh evaluationofhepatitiscviruscoreantigeninimmunizedbalbcmice AT kazemibahram evaluationofhepatitiscviruscoreantigeninimmunizedbalbcmice |